Literature DB >> 16611923

Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Tatsuo Kanda1, Arnab Basu, Robert Steele, Takaji Wakita, Jan S Ryerse, Ranjit Ray, Ratna B Ray.   

Abstract

Progress in understanding hepatitis C virus (HCV) biology has remained a challenge due to the lack of an efficient cell culture system for virus growth. In this study, we examined HCV core protein-mediated immortalized human hepatocytes (IHH) for growth of HCV. In vitro-transcribed full-length RNA from HCV genotype 1a (clone H77) was introduced into IHH by electroporation. Reverse transcription-PCR of cellular RNA isolated from HCV genome-transfected IHH suggested that viral RNA replication occurred. IHH transfected with the full-length HCV genome also displayed viral protein expression by indirect immunofluorescence. In contrast, cells transfected with polymerase-defective HCV (H77/GND) RNA as a negative control did not exhibit expression of the viral genome. Immunogold labeling demonstrated localization of E1 protein in the rough endoplasmic reticulum of RNA-transfected IHH. Virus-like particles of approximately 50 nm were observed in the cytoplasm. After being inoculated with culture media of cells transfected with the full-length HCV genome, naïve IHH displayed NS5a protein expression in a dilution-dependent manner, but expression of NS5a was inhibited by prior incubation of culture medium with HCV-infected patient sera. NS5a-positive immunofluorescence of cell culture media of IHH transfected with full-length H77 RNA yielded approximately 4.5 x 10(4) to 1 x 10(5) focus-forming units/ml. A similar level of virus growth was observed upon transfection of RNA from HCV genotype 2a (JFH1) into IHH. Taken together, our results suggest that IHH support HCV genome replication and virus assembly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611923      PMCID: PMC1472020          DOI: 10.1128/JVI.80.9.4633-4639.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Current and evolving therapies for hepatitis C.

Authors:  D Moradpour; H E Blum
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-11       Impact factor: 2.566

2.  Hepatocellular carcinoma: an emerging problem with hepatitis C.

Authors:  L Jeffers
Journal:  J Natl Med Assoc       Date:  2000-08       Impact factor: 1.798

Review 3.  Hepatitis C virus core protein: intriguing properties and functional relevance.

Authors:  R B Ray; R Ray
Journal:  FEMS Microbiol Lett       Date:  2001-08-21       Impact factor: 2.742

4.  Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient.

Authors:  T Kato; A Furusaka; M Miyamoto; T Date; K Yasui; J Hiramoto; K Nagayama; T Tanaka; T Wakita
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

5.  Hepatitis C virus core protein promotes immortalization of primary human hepatocytes.

Authors:  R B Ray; K Meyer; R Ray
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

6.  Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Authors:  Masanori Ikeda; MinKyung Yi; Kui Li; Stanley M Lemon
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.

Authors:  Thomas Pietschmann; Volker Lohmann; Artur Kaul; Nicole Krieger; Gabriele Rinck; Gabriel Rutter; Dennis Strand; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.

Authors:  A Basu; K Meyer; R B Ray; R Ray
Journal:  Virology       Date:  2001-09-30       Impact factor: 3.616

9.  Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Authors:  MinKyung Yi; Rodrigo A Villanueva; David L Thomas; Takaji Wakita; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

10.  Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.

Authors:  Mainak Majumder; Asish K Ghosh; Robert Steele; Xiao Yan Zhou; Nancy J Phillips; Ranjit Ray; Ratna B Ray
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

View more
  60 in total

1.  Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.

Authors:  Shubham Shrivastava; Amit Raychoudhuri; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

2.  Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.

Authors:  Robert S Tacke; Hai-Chon Lee; Celeste Goh; Jeremy Courtney; Stephen J Polyak; Hugo R Rosen; Young S Hahn
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

3.  Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Authors:  Young-Chan Kwon; Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

4.  Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Authors:  Budhaditya Mazumdar; Hangeun Kim; Keith Meyer; Sandip K Bose; Adrian M Di Bisceglie; Ratna B Ray; Michael S Diamond; John P Atkinson; Ranjit Ray
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

5.  Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

Authors:  Budhaditya Mazumdar; Arup Banerjee; Keith Meyer; Ranjit Ray
Journal:  Hepatology       Date:  2011-07-25       Impact factor: 17.425

6.  Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes.

Authors:  Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.

Authors:  Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition.

Authors:  Arup Banerjee; Kousuke Saito; Keith Meyer; Sutapa Banerjee; Malika Ait-Goughoulte; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.

Authors:  Ranjit Ray; Keith Meyer; Arup Banerjee; Arnab Basu; Stephen Coates; Sergio Abrignani; Michael Houghton; Sharon E Frey; Robert B Belshe
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

10.  Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.